CASP8 and neoplasm: Weak caspase 8 expression is predictive of unfavourable progression-free survival (PFS) in medulloblastoma, where patients with low caspase 8 tumour levels had a 5-year PFS of 31%, compared with 73% in those with moderate or strong expression [34].